COL17A1 and non-small cell lung carcinoma: (95) also demonstrated the co-expression of the B cell targeted antigen bullous pemphigoid 180 (BP180) between healthy skin and NSCLC tissues and identified elevated anti-BP180 IgG at baseline that correlated with skin toxicities (p = 0.04), therapy response (p = 0.01) and overall survival (p = 0.04).